Literature DB >> 10642227

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.

M H Reacher1, A Shah, D M Livermore, M C Wale, C Graham, A P Johnson, H Heine, M A Monnickendam, K F Barker, D James, R C George.   

Abstract

OBJECTIVES: Determination of causes, trends, and antibiotic resistance in reports of bacterial pathogens isolated from blood in England and Wales from 1990 to 1998.
DESIGN: Description of bacterial isolates from blood, judged to be clinically significant by microbiology staff, reported to the Communicable Disease Surveillance Centre.
SETTING: Microbiology laboratories in England and Wales.
SUBJECTS: Patients yielding clinically significant isolates from blood. MAIN OUTCOME MEASURES: Frequency and Poisson regression analyses for trend of reported causes of bacteraemia and proportions of antibiotic resistant isolates.
RESULTS: There was an upward trend in total numbers of reports of bacteraemia. The five most cited organisms accounted for over 60% of reports each year. There was a substantial increase in the proportion of reports of Staphylococcus aureus resistant to methicillin, Streptococcus pneumoniae resistance to penicillin and erythromycin, and Enterococcus faecalis and Enterococcus faecium resistance to vancomycin. No increase was seen in resistance of Escherichia coli to gentamicin.
CONCLUSIONS: Reports from laboratories provide valuable information on trends and antibiotic resistance in bacteraemia and show a worrying increase in resistance to important antibiotics.

Entities:  

Mesh:

Year:  2000        PMID: 10642227      PMCID: PMC27266          DOI: 10.1136/bmj.320.7229.213

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

1.  Application of information technology to the laboratory reporting of communicable disease in England and Wales.

Authors:  A D Grant; B Eke
Journal:  Commun Dis Rep CDR Rev       Date:  1993-05-21

2.  Surveillance of outbreaks of small round structured virus infection.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1996-03-08

3.  Legionnaires' disease in Corby, Northamptonshire.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1997-01-17

4.  Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95.

Authors:  D C Speller; A P Johnson; D James; R R Marples; A Charlett; R C George
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

5.  Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood.

Authors:  F R Cockerill; J G Hughes; E A Vetter; R A Mueller; A L Weaver; D M Ilstrup; J E Rosenblatt; W R Wilson
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

6.  Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme.

Authors:  R M Hargreaves; M P Slack; A J Howard; E Anderson; M E Ramsay
Journal:  BMJ       Date:  1996-01-20

7.  Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing.

Authors:  D M Livermore; E J Threlfall; M H Reacher; A P Johnson; D James; T Cheasty; A Shah; F Warburton; A V Swan; J Skinner; A Graham; D C Speller
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

8.  Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.

Authors:  H Laurichesse; O Grimaud; P Waight; A P Johnson; R C George; E Miller
Journal:  Commun Dis Public Health       Date:  1998-03

9.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

10.  Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.

Authors:  D Pittet; R P Wenzel
Journal:  Arch Intern Med       Date:  1995-06-12
View more
  49 in total

1.  Guidelines for managing acute bacterial meningitis.

Authors:  K Moller; P Skinhoj
Journal:  BMJ       Date:  2000-05-13

2.  The rise in bacterial resistance is partly because there have been no new classes of antibiotics since the 1960s.

Authors:  S G Amyes
Journal:  BMJ       Date:  2000-01-22

Review 3.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Guidelines for managing acute bacterial meningitis in adults

Authors: 
Journal:  West J Med       Date:  2000-10

5.  Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates.

Authors:  N S Crowcroft; M Catchpole
Journal:  BMJ       Date:  2002-12-14

6.  Controlling methicillin resistant Staphylococcus aureus.

Authors:  Georgia Duckworth
Journal:  BMJ       Date:  2003-11-22

7.  Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era.

Authors:  S H Allen; P Brennan-Benson; M Nelson; D Asboe; M Bower; B Azadian; B Gazzard; J Stebbing
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

Review 8.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

9.  Health protection and a new strategy for combating infection in children.

Authors:  E G Davies; M Sharland; A Nicoll
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

Review 10.  Surveillance of antibiotic resistance.

Authors:  Alan P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.